arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Catheter Precision, Inc.

VTAK
$0.15 0.00 (0.00%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
38 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
18
Health
Poor
Bearish
auto_awesome

Analytical Summary

Catheter Precision, Inc. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap —
Dividend Yield —
Revenue Growth 380.7% ↗
Op. Margin -388.1%
ROIC -20.6% ↗
FCF / Share $-1.04 ↗
Trailing P/E —
Price / Book 0.0x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Oct 2, 2026.

38-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.02M
↑ +380.7% —
Net Income Profit after all expenses
$-3.29M
↑ +35.5% —
Operating Margin Operating profit as % of sales
-388.1%
↓ -66.7% —
FCF / Share Free cash flow per share
$-1.04
↑ +18.7% —
Long-Term Debt Long-term obligations
$3.08M
↑ +105.2% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓
1
Financial Health →
29
Cash Quality ↓
39

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 10 years · 38 quarters